Financhill
Back

BioXcel Therapeutics Vs. Axsome Therapeutics Industry Stock Comparison

Sell
7

BTAI
BioXcel Therapeutics

Last Price:
$1.18
Seasonality Move:
-27.12%
Sell
45

AXSM
Axsome Therapeutics

Last Price:
$105.15
Seasonality Move:
11.24%
Sell
7
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $1.18. The Score for BTAI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $105.16. The Score for AXSM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $1.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight selling pressure.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $105.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 27.78 Sell
Chaikin Money Flow: -82172 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.76) Sell
Bollinger Bands (100): (1.12 - 4.46) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.3 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: 359502 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.64 - 111.3) Sell
Bollinger Bands (100): (97.44 - 123.32) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.33 Sell
20-day SMA: 1.45 Sell
50-day SMA: 1.72 Sell
200-day SMA: 5.83 Sell
8-day EMA: 1.31 Sell
20-day EMA: 1.45 Sell
50-day EMA: 1.87 Sell
200-day EMA: 10.93 Sell

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.04 Buy
20-day SMA: 107.56 Sell
50-day SMA: 108.6 Sell
200-day SMA: 100.76 Buy
8-day EMA: 105.1 Buy
20-day EMA: 106.41 Sell
50-day EMA: 108.37 Sell
200-day EMA: 101.54 Buy

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.16 per share, and a decrease next year of $0.77 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.99 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):